Am J Physiol Cell Physiol Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Cell Physiol 291: C445-C455, 2006. First published April 12, 2006; doi:10.1152/ajpcell.00505.2005
0363-6143/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/3/C445    most recent
00505.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kidane, T. Z.
Right arrow Articles by Linder, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kidane, T. Z.
Right arrow Articles by Linder, M. C.

CELLULAR METABOLISM

Release of iron from ferritin requires lysosomal activity

Theodros Z. Kidane, Eric Sauble, and Maria C. Linder

Department of Chemistry and Biochemistry and Institute for Molecular Biology and Nutrition, California State University, Fullerton, California

Submitted 9 October 2005 ; accepted in final form 25 March 2006

How ferritin-Fe becomes available for cell functions is unknown. Our previous studies with rat hepatoma cells indicated ferritin had to be degraded to release its Fe. In these studies, we investigated whether this occurs in other cell types and whether lysosomes are required. Release of ferritin-Fe was induced with desferoxamine (DFO) in 59Fe-preloaded hepatoma, Caco2, and erythroid K562 cells and measured by rocket immunoelectrophoresis and autoradiography. The half-lives for ferritin-59Fe and protein were parallel (23, 16, and 11 h for the hepatic, Caco2, and K562 cells, respectively). Co-treatment with 180 µM Fe, leupeptin, chymostatin, or chloroquine markedly decreased rates of ferritin-Fe release and ferritin degradation. Lactacystin had no effect except for a small one in erythroid cells. Fractionation of hepatoma cell lysates on iodixanol gradients showed rapid depletion of cytosolic ferritin by DFO treatment but no accumulation in lysosomes. We conclude that regardless of cell type, release of Fe from ferritin occurs mainly through lysosomal proteolysis.

degradation; proteasomes


Address for reprint requests and other correspondence: M. C. Linder, Dept. of Chemistry and Biochemistry, California State Univ., Fullerton, CA 91834-6866 (e-mail: mlinder{at}fullerton.edu)




This article has been cited by other articles:


Home page
 Eur Respir JHome page
H. L. Persson and L. K. Vainikka
Lysosomal iron in pulmonary alveolar proteinosis: a case report
Eur. Respir. J., March 1, 2009; 33(3): 673 - 679.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
W. Li, L.-H. Xu, C. Forssell, J. L. Sullivan, and X.-M. Yuan
Overexpression of Transferrin Receptor and Ferritin Related to Clinical Symptoms and Destabilization of Human Carotid Plaques
Experimental Biology and Medicine, July 1, 2008; 233(7): 818 - 826.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
D. Zhang, E. Meyron-Holtz, and T. A. Rouault
Renal Iron Metabolism: Transferrin Iron Delivery and the Role of Iron Regulatory Proteins
J. Am. Soc. Nephrol., February 1, 2007; 18(2): 401 - 406.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.